未登录

F

Fang Liu

Naval Medical University

H指数:20

被引数:1,603

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blocking TRIM47-mediated HNF4α degradation suppresses hepatocellular carcinoma progression

阻断TRIM47介导的HNF4α降解可抑制肝细胞癌进展

Acta Pharmaceutica Sinica B

IF14.6

2025-11-010

OAAI

Exosome-based immunotherapy in hepatocellular carcinoma

基于外泌体的肝癌免疫疗法

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2025-04-240

OA

TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4 a stability

TRIB3-TRIM8复合物通过调节HNF4 a稳定性驱动NAFLD进展

JOURNAL OF HEPATOLOGY

IF33

2024-05-0110

PRE

Discovery of highly selective novel MTA-cooperative PRMT5 inhibitors for the treatment of cancers

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Immunogenic PANoptosis-Initiated Cancer Sono-Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle

ADVANCED MATERIALS

IF26.8

2023-11-2330

PRE

A versatile electrospun polylactic acid nanofiber membrane integrated with halloysite nanotubes for indoor air purification, disinfection, and photocatalytic degradation of pollutants

SEPARATION AND PURIFICATION TECHNOLOGY

IF9

2023-10-0122

PRE

Identification of INHBA as a potential biomarker for gastric cancer through a comprehensive analysis

通过综合分析确定INHBA作为胃癌的潜在生物标志物

SCIENTIFIC REPORTS

IF3.9

2023-08-0110

OAAI

Dysfunction of the ST7-AS1/miR-301b-3p/BTG1 ceRNA network promotes immune escape of triple-negative breast cancer

ST7-AS1/miR-301b-3p/BTG1 ceRNA网络功能障碍促进三阴性乳腺癌免疫逃逸

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-03-011

PRE

Research and Application of Kupffer Cell Thresholds for BSA Nanoparticles

IF4.6

2023-01-165

OAAI

Inhibition of protein arginine methyltransferase 1 alleviates liver fibrosis by attenuating the activation of hepatic stellate cells in mice

抑制蛋白精氨酸甲基转移酶1通过减弱肝星状细胞活化减轻小鼠肝纤维化

IF4.2

2022-08-127

PRE

Cytoplasmic RAD23B interacts with CORO1C to synergistically promote colorectal cancer progression and metastasis

IF10.1

2021-09-0112

OAAI

Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-09-0112

PREAI

USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2021-06-2135

OAAI

A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance

IF7.3

2021-06-0227

PREAI

Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma

IF3.4

2020-10-229

OAAI

Identifying the active components of Baihe-Zhimu decoction that ameliorate depressive disease by an effective integrated strategy: a systemic pharmacokinetics study combined with classical depression model tests (vol 14, 37, 2019)

CHINESE MEDICINE

IF5.7

2020-04-020

OAAI

Sulforaphane suppresses carcinogenesis of colorectal cancer through the ERK/Nrf2-UDP glucuronosyltransferase 1A metabolic axis activation

ONCOLOGY REPORTS

IF3.9

2020-02-1038

OAAI

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma

CANCER CELL INTERNATIONAL

IF6

2019-09-276

OAAI

Determining the protective effects of Yin-Chen-Hao Tang against acute liver injury induced by carbon tetrachloride using 16S rRNA gene sequencing and LC/MS-based metabolomics

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2019-09-0134

PREAI

miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2 (vol 115, pg 1548, 2016)

BRITISH JOURNAL OF CANCER

IF6.8

2018-02-2014

OAAI